PAM50 intrinsic subtype classification (Parker JS, Mullins M, Cheang MCU, et al: Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. J Clin Oncol 27:1160-1167, 2009) was used for t
*Difference exists between subgroups; Luminal vs. Triple-negative, MD (Mean Difference) = 7.55, P = 0.002. Luminal vs. HER-2 overexpression, MD = 4.05, P = 0.212. Luminal vs. Unknown, MD = 1.61, P =
The Formalin-Fixed Paraffin-Embedded (FFPE) samples on selected breast cancer subtypes (ER+/Her2-, ER+/Her2+, ER-/Her2+, and ER-/Her2-) and their paired fresh fine needle aspirated biopsies (FNA) were
Table S1. Ranking of correlation coefficients in top 40 pairs of PTEN vs. miRNAs from each of the 14 subgroups. Table S2. Average ranking of correlation coefficients in top 40 miR pairs on 7â BC subgr
